Evidence for a two-stage disability progression in multiple sclerosis, Brain, vol.133, issue.7, pp.1900-1913, 2010. ,
DOI : 10.1093/brain/awq076
Multiple sclerosis: treatment of acute exacerbations with corticotrophin (ACTH), Lancet, vol.2, pp.1120-1142, 1961. ,
High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: Clinical-immunologic correlations, Neurology, vol.36, issue.2, pp.238-281, 1986. ,
DOI : 10.1212/WNL.36.2.238
A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects., Journal of Neurology, Neurosurgery & Psychiatry, vol.50, issue.5, pp.511-527, 1987. ,
DOI : 10.1136/jnnp.50.5.511
Experience of the Optic Neuritis Treatment Trial, Ophthalmology, vol.101, pp.1771-78, 1994. ,
What We Have Learned from the Optic Neuritis Treatment Trial, Ophthalmology, vol.102, issue.10, pp.1504-1512, 1995. ,
DOI : 10.1016/S0161-6420(95)30839-1
Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis, The Lancet, vol.349, issue.9066, p.1696, 1997. ,
DOI : 10.1016/S0140-6736(05)62663-3
Corticosteroids or ACTH for acute exacerbations in multiple sclerosis ,
DOI : 10.1002/14651858.CD001331
Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS, Neurology, vol.51, issue.2, pp.529-563, 1998. ,
DOI : 10.1212/WNL.51.2.529
A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis, Neurology, vol.52, issue.7, pp.1479-84, 1999. ,
DOI : 10.1212/WNL.52.7.1479
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis ,
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis, The Lancet, vol.349, issue.9056, pp.902-908, 1997. ,
DOI : 10.1016/S0140-6736(96)06453-7
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS, Multiple Sclerosis Journal, vol.130, issue.6, pp.717-725, 2014. ,
DOI : 10.1136/jnnp.55.6.450
A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS, Neurology, vol.73, issue.22, pp.1842-1890, 2009. ,
DOI : 10.1212/WNL.0b013e3181c3fd5b
The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis, Neurology, vol.63, issue.6, pp.1079-80, 2004. ,
DOI : 10.1212/01.WNL.0000138572.82125.F5
Defining the clinical course of multiple sclerosis: The 2013 revisions, Neurology, vol.83, issue.3, pp.278-86, 2014. ,
DOI : 10.1212/WNL.0000000000000560
Diagnostic criteria for multiple sclerosis: 2005 revisions to the ???McDonald Criteria???, Annals of Neurology, vol.6, issue.6 ,
DOI : 10.1002/ana.20703
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS), 21 International Conference on Harmonisation, pp.1444-52, 1983. ,
DOI : 10.1212/WNL.33.11.1444